Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Credit Suisse
Pharma
Galderma raises $1B through private placement
The Cetaphil maker remains hopeful for its long-eyed IPO despite multiple derailments.
Zoey Becker
Jun 27, 2023 11:02am
GSK's 'serial disappointments' dampen long-term outlook: analyst
Jan 21, 2021 10:41am
Xarelto scripts stagnate as discounts pile up
Apr 23, 2019 10:33am
Could a Celgene patent dispute tank the BMS deal?
Mar 13, 2019 11:23am
Analyst expresses doubt for approval of Teva migraine drug
Sep 7, 2018 10:52am
Merck rains on Roche's parade with double Keytruda win
May 23, 2018 12:35pm
